bioAffinity Technologies, Inc.
BIAFW- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001712762
No open-market purchases or sales by bioAffinity Technologies, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $18.1K in total; no superinvestor holds it.
Other share classesBIAF
Q2 2023 vs. Q1 2023
How the institutions holding bioAffinity Technologies, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 5 | 5 | 0 |
| Shares | 283.2K | 282.8K | −389 (−0.1%) |
| Value | $85.0K | $136.9K | +$52.0K (+61.1%) |
New holders (1)
Institutions that held bioAffinity Technologies, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 285 | $60 | 0.00% |
Sold out (1)
Institutions that held bioAffinity Technologies, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 14,077 | $4.22K |